New Guidelines Enhance Diagnosis and Treatment of Inflammatory Bowel Disease
Updated guidelines developed by the University of Nottingham aim to help clinicians diagnose and treat inflammatory bowel disease more accurately and rapidly, emphasizing early, effective therapy for better patient outcomes.
Scientists and clinicians at the University of Nottingham have developed updated guidelines to improve the management of inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. These new recommendations aim to enable healthcare providers to diagnose and treat IBD more accurately, efficiently, and effectively.
The revised guidelines, published in the journal BMJ Gut, serve as an evidence-based roadmap for the diagnosis, medical, and surgical management of IBD. They address critical areas such as the management of special conditions like pregnancy, treatment of extraintestinal manifestations, and drug monitoring. Importantly, these guidelines introduce a top-down therapy approach for the first time, advocating for early use of the most effective drugs rather than escalating treatment based on patient response.
Commissioned by the British Society of Gastroenterology (BSG), the guidelines build upon the previous 2019 version and incorporate the latest research, including extensive evidence syntheses and network meta-analyses. Developed using the GRADE methodology, they offer clear, practical recommendations intended to assist clinicians both nationally and internationally.
Professor Gordon Moran of the University of Nottingham emphasized the importance of these guidelines, highlighting the comprehensive review of therapeutic agents for remission induction and maintenance in IBD. The collaboration involved experts, generalists, and patients, ensuring the guidance reflects current evidence and real-world needs.
These updates are part of a wider effort to streamline diagnostic pathways and promote high-quality, multidisciplinary care for IBD patients. The guidelines are expected to facilitate quicker, more precise diagnosis and optimal treatment strategies, ultimately improving patient outcomes and quality of life.
Source: https://medicalxpress.com/news/2025-06-guidance-inflammatory-bowel-disease-quicker.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Retinal Imaging in Mice Detects Early Immune Activity Before Onset of Diabetic Eye Damage
A groundbreaking retinal imaging technique in mice uncovers early immune cell activity that precedes diabetic eye damage, paving the way for early diagnosis and treatment of vision-related diseases.
New Research Reveals Deep Brain Regions Integrate Sensory Input to Trigger Consciousness
A groundbreaking Yale study reveals that deep brain regions like the midbrain and thalamus are activated by all sensory inputs during focused attention, linking them to consciousness and offering new insights into neurological disorders.
Innovative Foam Treatment Offers Rapid Relief for Itching and Persistent Scalp Psoriasis
A new foam formulation of roflumilast shows rapid itch relief and significant clearance of scalp and body psoriasis lesions in a clinical trial, offering a promising treatment option for patients with challenging psoriasis.
New Insights into How Your Brain Chooses Between Healthy and Sweet Foods
New research reveals that multiple brain regions, including the mediodorsal thalamus, influence how we perceive and anticipate flavors, shaping our food preferences and choices between healthy and sweet foods.